Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer
Silvia Sabbioni(University of Ferrara), Elisa Callegari(University of Ferrara)
Cited by 2
Related Papers
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the <i>BWR1A</i> gene reveals the presence of mutations in tumor samples
|Proceedings of the National Academy of Sciences|1998|56
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
|Molecular Therapy — Nucleic Acids|2018|23
A comprehensive approach for microbiota and health monitoring in mouse colonies using metagenomic shotgun sequencing
|Animal Microbiome|2021|19
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models
|Molecular Therapy — Nucleic Acids|2022|14